Search results
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi By Proactive Investors
Investing.com· 6 days agoThe deal encompasses the commercialization of a combined COVID-19 and flu shot, marking a pivotal...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga· 6 days agoNovavax has a sole license to its adjuvanted COVID-19 vaccine for use in combination with Sanofi’s...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 5 days agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 6 days agoThe company, a prominent player in the biotechnology sector focusing on the development of vaccines, reported a net loss of $147.55 million with a loss per share of $1.05.
French, US drug firms team up for Covid-flu shot
AFP via Yahoo Finance· 6 days agoFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines...
Novavax's Options: A Look at What the Big Money is Thinking - Novavax (NASDAQ:NVAX)
Benzinga· 16 hours agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly ...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 3 days agoThe deal, which includes upfront and milestone payments of around $1.3 billion, half of which is...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 3 days agoNovavax will receive $500 million in upfront payments as well as a further $700 million if all...
The Sanofi-Novavax vaccine deal is worth up to $1.2 billion
The Port Lavaca Wave· 6 days agoThe Sanofi-Novavax vaccine deal is worth up to $1.2 billion
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 6 days agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...